vs
AdvanSix Inc.（ASIX）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是Tilray Brands, Inc.的1.7倍（$359.9M vs $217.5M），AdvanSix Inc.净利率更高（-0.8% vs -20.7%，领先19.9%），AdvanSix Inc.同比增速更快（9.4% vs 3.1%），过去两年Tilray Brands, Inc.的营收复合增速更高（7.5% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
ASIX vs TLRY — 直观对比
营收规模更大
ASIX
是对方的1.7倍
$217.5M
营收增速更快
ASIX
高出6.3%
3.1%
净利率更高
ASIX
高出19.9%
-20.7%
两年增速更快
TLRY
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $217.5M |
| 净利润 | $-2.8M | $-44.9M |
| 毛利率 | 7.6% | 26.4% |
| 营业利润率 | -0.7% | -10.2% |
| 净利率 | -0.8% | -20.7% |
| 营收同比 | 9.4% | 3.1% |
| 净利润同比 | -892.9% | 47.4% |
| 每股收益（稀释后） | $-0.11 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXTLRY
| Q4 25 | $359.9M | $217.5M | ||
| Q3 25 | $374.5M | $209.5M | ||
| Q2 25 | $410.0M | $224.5M | ||
| Q1 25 | $377.8M | $185.8M | ||
| Q4 24 | $329.1M | $210.9M | ||
| Q3 24 | $398.2M | $200.0M | ||
| Q2 24 | $453.5M | $229.9M | ||
| Q1 24 | $336.8M | $188.3M |
净利润ASIXTLRY
| Q4 25 | $-2.8M | $-44.9M | ||
| Q3 25 | $-2.6M | $-322.0K | ||
| Q2 25 | $31.4M | $-1.3B | ||
| Q1 25 | $23.3M | $-789.4M | ||
| Q4 24 | $352.0K | $-85.3M | ||
| Q3 24 | $22.3M | $-39.2M | ||
| Q2 24 | $38.9M | $-31.7M | ||
| Q1 24 | $-17.4M | $-92.7M |
毛利率ASIXTLRY
| Q4 25 | 7.6% | 26.4% | ||
| Q3 25 | 6.8% | 27.4% | ||
| Q2 25 | 14.3% | 30.1% | ||
| Q1 25 | 14.2% | 28.0% | ||
| Q4 24 | 3.4% | 29.0% | ||
| Q3 24 | 14.4% | 29.8% | ||
| Q2 24 | 17.9% | 35.8% | ||
| Q1 24 | 0.9% | 26.2% |
营业利润率ASIXTLRY
| Q4 25 | -0.7% | -10.2% | ||
| Q3 25 | -0.9% | 1.0% | ||
| Q2 25 | 7.7% | -643.1% | ||
| Q1 25 | 7.7% | -409.0% | ||
| Q4 24 | -3.9% | -20.0% | ||
| Q3 24 | 7.5% | -18.3% | ||
| Q2 24 | 11.5% | -7.2% | ||
| Q1 24 | -7.0% | -43.6% |
净利率ASIXTLRY
| Q4 25 | -0.8% | -20.7% | ||
| Q3 25 | -0.7% | -0.2% | ||
| Q2 25 | 7.7% | -566.9% | ||
| Q1 25 | 6.2% | -424.9% | ||
| Q4 24 | 0.1% | -40.5% | ||
| Q3 24 | 5.6% | -19.6% | ||
| Q2 24 | 8.6% | -13.8% | ||
| Q1 24 | -5.2% | -49.2% |
每股收益（稀释后）ASIXTLRY
| Q4 25 | $-0.11 | $-0.41 | ||
| Q3 25 | $-0.10 | $0.00 | ||
| Q2 25 | $1.15 | $7.26 | ||
| Q1 25 | $0.86 | $-8.69 | ||
| Q4 24 | $0.02 | $-0.99 | ||
| Q3 24 | $0.82 | $-0.04 | ||
| Q2 24 | $1.43 | $-0.04 | ||
| Q1 24 | $-0.65 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $815.2M | $1.6B |
| 总资产 | $1.7B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASIXTLRY
| Q4 25 | $19.8M | $291.6M | ||
| Q3 25 | $23.7M | $264.8M | ||
| Q2 25 | $18.4M | $256.4M | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $19.6M | $252.2M | ||
| Q3 24 | $17.3M | $280.1M | ||
| Q2 24 | $12.1M | $260.5M | ||
| Q1 24 | $20.6M | $225.9M |
股东权益ASIXTLRY
| Q4 25 | $815.2M | $1.6B | ||
| Q3 25 | $818.2M | $1.5B | ||
| Q2 25 | $823.7M | $1.5B | ||
| Q1 25 | $794.4M | $2.7B | ||
| Q4 24 | $774.6M | $3.5B | ||
| Q3 24 | $766.4M | $3.5B | ||
| Q2 24 | $746.6M | $3.4B | ||
| Q1 24 | $713.2M | $3.4B |
总资产ASIXTLRY
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.6B | $2.1B | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.5B | $4.3B | ||
| Q2 24 | $1.5B | $4.2B | ||
| Q1 24 | $1.5B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXTLRY
| Q4 25 | $63.7M | $-8.5M | ||
| Q3 25 | $26.6M | $-1.3M | ||
| Q2 25 | $21.1M | $-12.8M | ||
| Q1 25 | $11.4M | $-5.8M | ||
| Q4 24 | $64.2M | $-40.7M | ||
| Q3 24 | $57.3M | $-35.3M | ||
| Q2 24 | $50.2M | $30.7M | ||
| Q1 24 | $-36.2M | $-15.4M |
自由现金流ASIXTLRY
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | $-19.1M | ||
| Q1 25 | $-22.6M | $-20.2M | ||
| Q4 24 | $29.8M | $-46.2M | ||
| Q3 24 | $26.8M | $-42.0M | ||
| Q2 24 | $16.7M | $21.0M | ||
| Q1 24 | $-71.6M | $-24.9M |
自由现金流率ASIXTLRY
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | -8.5% | ||
| Q1 25 | -6.0% | -10.9% | ||
| Q4 24 | 9.1% | -21.9% | ||
| Q3 24 | 6.7% | -21.0% | ||
| Q2 24 | 3.7% | 9.1% | ||
| Q1 24 | -21.3% | -13.2% |
资本支出强度ASIXTLRY
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | 2.8% | ||
| Q1 25 | 9.0% | 7.8% | ||
| Q4 24 | 10.4% | 2.6% | ||
| Q3 24 | 7.7% | 3.4% | ||
| Q2 24 | 7.4% | 4.2% | ||
| Q1 24 | 10.5% | 5.1% |
现金转化率ASIXTLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
